Search

Your search keyword '"Lichter-Konecki, Uta"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Lichter-Konecki, Uta" Remove constraint Author: "Lichter-Konecki, Uta" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
133 results on '"Lichter-Konecki, Uta"'

Search Results

4. Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency

5. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy

6. Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials

7. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder

8. Late diagnosis of the X-linked MCT8 deficiency (Allan–Herndon–Dudley syndrome) in a teenage girl with primary ovarian insufficiency.

12. Correction to: Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency

14. CURATION OF SEQUENCE VARIANTS IN UREA CYCLE GENES

16. Contributors

18. Multisite Retrospective Review of Outcomes in Renal Replacement Therapy for Neonates with Inborn Errors of Metabolism

19. Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania

20. Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency

21. MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase

24. Refining ClinGen loss of function variant recommendations for the phenylalanine hydroxylase (PAH) gene: the PAH variant curation expert panel’s experience

25. Opportunities for fellowship education: the first year of the Medical Biochemical Genetics Clinical Core Seminar Series

26. The Genetic Landscape and Epidemiology of Phenylketonuria

27. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders

28. A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing

29. The Genetic Landscape and Epidemiology of Phenylketonuria

31. Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain‐specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events

32. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-A successful strategy for clinical research of rare diseases

33. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients

35. Conducting an investigator-initiated randomized double-blinded intervention trial in acute decompensation of inborn errors of metabolism: Lessons from the N-Carbamylglutamate Consortium

36. Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders

38. BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS

39. Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure

40. Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure

42. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years

44. The Pennsylvania newborn screening experience for Pompe disease

45. Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene.

Catalog

Books, media, physical & digital resources